These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 23541085)

  • 21. Genome-wide epigenetic analysis delineates a biologically distinct immature acute leukemia with myeloid/T-lymphoid features.
    Figueroa ME; Wouters BJ; Skrabanek L; Glass J; Li Y; Erpelinck-Verschueren CA; Langerak AW; Löwenberg B; Fazzari M; Greally JM; Valk PJ; Melnick A; Delwel R
    Blood; 2009 Mar; 113(12):2795-804. PubMed ID: 19168792
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aberrant methylation of CCAAT/enhancer binding protein zeta promoter in acute myeloid leukemia.
    Yao DM; Qian J; Lin J; Wang YL; Chen Q; Qian Z; Li Y; Wang CZ; Yang J
    Leuk Res; 2011 Jul; 35(7):957-60. PubMed ID: 21106240
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Methylation status of JunB and CDH13 gene promoter in CD34(+)CD38(-) chronic myelogenous leukemia cells].
    Wang XJ; Li J; Fu BJ; Guo LL; Zhang JH; Huang SA
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Dec; 17(6):1405-8. PubMed ID: 20030915
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Down-regulation of hematopoiesis master regulator PU.1 via aberrant methylation in chronic myeloid leukemia.
    Yang H; Liang H; Yan JS; Tao R; Hao SG; Ma LY
    Int J Hematol; 2012 Jul; 96(1):65-73. PubMed ID: 22674382
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MEF2C and CEBPA: Possible co-regulators in chronic myeloid leukemia disease progression.
    Agatheeswaran S; Chakraborty S
    Int J Biochem Cell Biol; 2016 Aug; 77(Pt A):165-170. PubMed ID: 27297623
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The CEBPA gene is down-regulated in acute promyelocytic leukemia and its upstream promoter, but not the core promoter, is highly methylated.
    Santana-Lemos BA; de Lima Lange AP; de Lira Benício MT; José TD; Lucena-Araújo AR; Krause A; Thomé CH; Rego EM
    Haematologica; 2011 Apr; 96(4):617-20. PubMed ID: 21134977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epigenetic inactivation of DLX4 is associated with disease progression in chronic myeloid leukemia.
    Zhou JD; Wang YX; Zhang TJ; Yang DQ; Yao DM; Guo H; Yang L; Ma JC; Wen XM; Yang J; Lin J; Qian J
    Biochem Biophys Res Commun; 2015 Aug; 463(4):1250-6. PubMed ID: 26086097
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DNA methyltransferase 1 mediated aberrant methylation and silencing of SHP-1 gene in chronic myelogenous leukemia cells.
    Li Y; Liu X; Guo X; Liu X; Luo J
    Leuk Res; 2017 Jul; 58():9-13. PubMed ID: 28376405
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detailed mapping of methylcytosine positions at the CpG island surrounding the Pa promoter at the bcr-abl locus in CML patients and in two cell lines, K562 and BV173.
    Fajkusová L; Fajkus J; Polácková K; Fulnecek J; Dvoráková D; Krahulcová E
    Blood Cells Mol Dis; 2000 Jun; 26(3):193-204. PubMed ID: 10950939
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aberrant DNA methylation of the transcription factor C/EBPalpha in acute myelogenous leukemia.
    Jost E; do O N; Wilop S; Herman JG; Osieka R; Galm O
    Leuk Res; 2009 Mar; 33(3):443-9. PubMed ID: 18757096
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Abnormal methylation of the common PARK2 and PACRG promoter is associated with downregulation of gene expression in acute lymphoblastic leukemia and chronic myeloid leukemia.
    Agirre X; Román-Gómez J; Vázquez I; Jiménez-Velasco A; Garate L; Montiel-Duarte C; Artieda P; Cordeu L; Lahortiga I; Calasanz MJ; Heiniger A; Torres A; Minna JD; Prósper F
    Int J Cancer; 2006 Apr; 118(8):1945-53. PubMed ID: 16287063
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aberrant DNA methylation of PTPRG as one possible mechanism of its under-expression in CML patients in the State of Qatar.
    Ismail MA; Samara M; Al Sayab A; Alsharshani M; Yassin MA; Varadharaj G; Vezzalini M; Tomasello L; Monne M; Morsi H; Qoronfleh MW; Zayed H; Cook R; Sorio C; Modjtahedi H; Al-Dewik NI
    Mol Genet Genomic Med; 2020 Oct; 8(10):e1319. PubMed ID: 32700424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protein tyrosine phosphatase receptor type {gamma} is a functional tumor suppressor gene specifically downregulated in chronic myeloid leukemia.
    Della Peruta M; Martinelli G; Moratti E; Pintani D; Vezzalini M; Mafficini A; Grafone T; Iacobucci I; Soverini S; Murineddu M; Vinante F; Tecchio C; Piras G; Gabbas A; Monne M; Sorio C
    Cancer Res; 2010 Nov; 70(21):8896-906. PubMed ID: 20959494
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Somatic CEBPA mutations are a frequent second event in families with germline CEBPA mutations and familial acute myeloid leukemia.
    Pabst T; Eyholzer M; Haefliger S; Schardt J; Mueller BU
    J Clin Oncol; 2008 Nov; 26(31):5088-93. PubMed ID: 18768433
    [TBL] [Abstract][Full Text] [Related]  

  • 35. sFRP1 promoter methylation is associated with persistent Philadelphia chromosome in chronic myeloid leukemia.
    Pehlivan M; Sercan Z; Sercan HO
    Leuk Res; 2009 Aug; 33(8):1062-7. PubMed ID: 19118898
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Infrequent hypermethylation of CEBPA promotor in acute myeloid leukaemia.
    Chim CS; Wong AS; Kwong YL
    Br J Haematol; 2002 Dec; 119(4):988-90. PubMed ID: 12472578
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [CEBPA gene mutation analysis in acute myeloid leukemia].
    Han C; Lin D; Ai XF; Wang F; Sun HY; Wang M; Mi YC; Wang JX; Ru K
    Zhonghua Xue Ye Xue Za Zhi; 2013 Jul; 34(7):566-71. PubMed ID: 23906447
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A regulatory element in the 3'-untranslated region of CEBPA is associated with myeloid/NK/T-cell leukemia.
    Kimura Y; Iwanaga E; Iwanaga K; Endo S; Inoue Y; Tokunaga K; Nagahata Y; Masuda K; Kawamoto H; Matsuoka M
    Eur J Haematol; 2021 Mar; 106(3):327-339. PubMed ID: 33197296
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CEBPA gene mutations in Egyptian acute myeloid leukemia patients: impact on prognosis.
    Awad MM; Aladle DA; Abousamra NK; Elghannam DM; Fawzy IM
    Hematology; 2013 Mar; 18(2):61-8. PubMed ID: 22990006
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SLIT2 promoter hypermethylation predicts disease progression in chronic myeloid leukemia.
    Wu DL; Wang Y; Zhang TJ; Chu MQ; Xu ZJ; Yuan Q; Ma JC; Lin J; Qian J; Zhou JD
    Eur J Med Res; 2022 Nov; 27(1):259. PubMed ID: 36411451
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.